Alterations in prednisolone disposition as a result of time of administration, gender and dose.

Por Meffin, P J, Brooks, P M, Sallustio, B C
Publicado em 1984

Electrophysiological effects of acebutolol.

Por Mason, J W, Winkle, R A, Meffin, P J, Harrison, D C
Publicado em 1978

Acebutolol metabolite plasma concentration during chronic oral therapy.

Por Winkle, R A, Meffin, P J, Ricks, W B, Harrison, D C
Publicado em 1977

Alterations in prednisolone disposition as a result of oral contraceptive use and dose.

Por Meffin, P J, Wing, L M, Sallustio, B C, Brooks, P M
Publicado em 1984

The disposition of ketoprofen enantiomers in man.

Por Sallustio, B C, Purdie, Y J, Whitehead, A G, Ahern, M J, Meffin, P J
Publicado em 1988

Ranitidine disposition in patients with renal impairment.

Por Meffin, P J, Grgurinovich, N, Brooks, P M, Miners, J O, Cochran, M, Stranks, G
Publicado em 1983

The effect of metoclopramide and atropine on the absorption of orally administered mexiletine.

Por Wing, L M, Meffin, P J, Grygiel, J J, Smith, K J, Birkett, D J
Publicado em 1980

Cortisol does not inhibit prednisolone clearance.

Por Meffin, P J, Sallustio, B C, Purdie, Y J, Robson, R A, Wing, L M, Brooks, P M
Publicado em 1985